Ryvu Therapeutics raised €22M in a funding round in Aug 2022. The company is based in Warsaw, Poland. Investors in the round: European Fund for Strategic Investments, European Investment Bank (EIB). Data as of 26 Sept 2026.
Reported in EUR — no conversion. €22M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
